Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Parker CC, Clarke NW, Cook AD, Kynaston HG, Petersen PM, Catton C, Cross W, Logue J, Parulekar W, Payne H, Persad R, Pickering H, Saad F, Anderson J, Bahl A, Bottomley D, Brasso K, Chahal R, Cooke PW, Eddy B, Gibbs S, Goh C, Gujral S, Heath C, Henderson A, Jaganathan R, Jakobsen H, James ND, Kanaga Sundaram S, Lees K, Lester J, Lindberg H, Money-Kyrle J, Morris S, O'Sullivan J, Ostler P, Owen L, Patel P, Pope A, Popert R, Raman R, Røder MA, Sayers I, Simms M, Wilson J, Zarkar A, Parmar MKB, Sydes MR.
Lancet. 2020 Oct 31;396(10260):1413-1421. doi: 10.1016/S0140-6736(20)31553-1. Epub 2020 Sep 28.
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).
Parker CC, Petersen PM, Cook AD, Clarke NW, Catton C, Cross WR, Kynaston H, Parulekar WR, Persad RA, Saad F, Bower L, Durkan GC, Logue J, Maniatis C, Noor D, Payne H, Anderson J, Bahl AK, Bashir F, Bottomley DM, Brasso K, Capaldi L, Chung C, Cooke PW, Donohue JF, Eddy B, Heath CM, Henderson A, Henry A, Jaganathan R, Jakobsen H, James ND, Joseph J, Lees K, Lester J, Lindberg H, Makar A, Morris SL, Oommen N, Ostler P, Owen L, Patel P, Pope A, Popert R, Raman R, Ramani V, Røder A, Sayers I, Simms M, Srinivasan V, Sundaram S, Tarver KL, Tran A, Wells P, Wilson J, Zarkar AM, Parmar MKB, Sydes MR; RADICALS investigators.
Ann Oncol. 2024 Jul;35(7):656-666. doi: 10.1016/j.annonc.2024.03.010. Epub 2024 Apr 5.
Radiotherapy following radical prostatectomy.
Patel P, Lee WR.
Expert Rev Anticancer Ther. 2012 Jul;12(7):973-9. doi: 10.1586/era.12.66.
The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.
Ashton M, O'Rourke N, Currie S, Rimner A, Chalmers A.
Radiother Oncol. 2017 Oct;125(1):1-12. doi: 10.1016/j.radonc.2017.08.003. Epub 2017 Aug 28.
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
Gandaglia G, Briganti A, Clarke N, Karnes RJ, Graefen M, Ost P, Zietman AL, Roach M 3rd.
Eur Urol. 2017 Nov;72(5):689-709. doi: 10.1016/j.eururo.2017.01.039. Epub 2017 Feb 8.
The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients.
Shuang H, Feng J, Caineng C, Qifeng J, Tin J, Yuanyuan C, Xiaozhong C.
Clin Transl Oncol. 2019 Feb;21(2):213-219. doi: 10.1007/s12094-018-1911-7. Epub 2018 Jun 25.
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
Rowell NP, Williams CJ.
Cochrane Database Syst Rev. 2001;(1):CD002935. doi: 10.1002/14651858.CD002935.
Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable).
Rowell NP, Williams CJ.
Cochrane Database Syst Rev. 2001;(2):CD002935. doi: 10.1002/14651858.CD002935.
Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer.
Li J, Wen Y, Xiang Z, Du H, Geng L, Yang X, Zhang Y, Bai J, Dai T, Feng G, Liu L, Du X.
Radiother Oncol. 2021 Jan;154:201-206. doi: 10.1016/j.radonc.2020.09.042. Epub 2020 Sep 25.
Salvage radiotherapy following radical prostatectomy.
Chalasani V, Iansavichene AE, Lock M, Izawa JI.
Int J Urol. 2009 Jan;16(1):31-6. doi: 10.1111/j.1442-2042.2008.02144.x. Epub 2008 Aug 20.
